123 related articles for article (PubMed ID: 9886595)
1. Multifocality of transitional cell carcinoma results from genetic instability of entire transitional epithelium.
Pycha A; Mian C; Hofbauer J; Brössner C; Haitel A; Wiener H; Marberger M
Urology; 1999 Jan; 53(1):92-7. PubMed ID: 9886595
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer.
Pycha A; Mian C; Haitel A; Hofbauer J; Wiener H; Marberger M
J Urol; 1997 Jun; 157(6):2116-9. PubMed ID: 9146595
[TBL] [Abstract][Full Text] [Related]
3. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
Yu DS; Chen HI; Chang SY
Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
[TBL] [Abstract][Full Text] [Related]
5. p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.
Rodríguez-Alonso A; Pita-Fernández S; González-Carreró J; Nogueira-March JL
Eur Urol; 2002 Feb; 41(2):182-8; discussion 188-9. PubMed ID: 12074407
[TBL] [Abstract][Full Text] [Related]
6. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
[TBL] [Abstract][Full Text] [Related]
8. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
10. Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas.
Yamamoto Y; Misumi T; Eguchi S; Chochi Y; Kitahara S; Nakao M; Nagao K; Hara T; Sakano S; Furuya T; Oga A; Kawauchi S; Sasaki K; Matsuyama H
Hum Pathol; 2011 Dec; 42(12):1923-30. PubMed ID: 21683985
[TBL] [Abstract][Full Text] [Related]
11. Chromosome instability and progression in urothelial cell carcinoma of the bladder.
Santos L; Pereira S; Leite RP; Souto M; Amaro T; Criado B
Acta Oncol; 2003; 42(2):169-73. PubMed ID: 12801136
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
[TBL] [Abstract][Full Text] [Related]
15. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma.
Ham WS; Lee JH; Yu HS; Choi YD
Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
17. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei.
Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH
Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic analysis of upper urinary tract transitional cell carcinomas.
Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Rademark C; Heim S
Cancer Genet Cytogenet; 1999 Dec; 115(2):123-7. PubMed ID: 10598145
[TBL] [Abstract][Full Text] [Related]
19. [The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer].
Kawamura K; Ikeda R; Suzuki K
Hinyokika Kiyo; 2000 Jun; 46(6):377-83. PubMed ID: 10934605
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
